Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Family Study of Lymphoproliferative Disorders
- Status
- RECRUITING
- Phase
- N/A
Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants
- Status
- COMPLETED
- Phase
- PHASE4
A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Peripheral Blood Stem Cell Transplantation (PBSCT)From Haploidentical Related Donors
- Status
- COMPLETED
- Phase
- PHASE2
Pegylated Liposomal Doxorubicin, Low Freq Dexamethasone & Revlimid (Dd-R) in Newly Diagnosed Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE2
Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy Study of GCS-100LE in the Treatment of Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)
- Status
- COMPLETED
- Phase
- PHASE1
T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Matched Unrelated Donor Stem Cell Transplantation (MUD-SCT) After Dose-reduced Conditioning for Patients With Multiple Myeloma and Relapse After Autologous SCT
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT)
- Status
- UNKNOWN
- Phase
- PHASE2
In-Vivo Activated T-Cell Depletion to Prevent GVHD
- Status
- TERMINATED
- Phase
- NA
Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Trial of ZIO-101 in Hematologic Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2